Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arch Med Res ; 49(8): 620-629, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-30446246

RESUMO

BACKGROUND: No reflow defined as an altered myocardial reperfusion and failure at microvascular level is a frequent complication in acute myocardial infarction that attenuates beneficial effect of reperfusion therapy leading to poor outcomes. There is not enough evidence to support that previous use of statins improves coronary flow in patients undergoing primary percutaneous coronary intervention (PCI). AIM OF STUDY: To determine if a loading dose of 80 mg of atorvastatin before primary angioplasty reduces the frequency of no reflow, hs-CRP, IL6 intracoronary levels, and major combined cardiovascular events at 30 d. METHODS: In this controlled clinical trial, we randomly assigned 103 adult patients within the 12 h of acute ST-elevation myocardial infarction (STEMI) to receive 80 mg of atorvastatin additional to standard treatment (AST) before performing primary PCI versus standard treatment (ST) alone. The primary outcomes were the occurrence of no reflow and high sensitivity C-reactive protein (hs-CRP) and interleukin 6 levels and secondary outcomes were major adverse cardiovascular events at 30 d. RESULTS: 103 patients were analyzed, 49 (48%) received AST, 54 (52%) ST. Frequency of no reflow among groups was 27 vs. 63% respectively, p ≤0.0001. hs-CRP level was 2.69 mg/dL for AST vs. 2.2 mg/dL in ST, meanwhile IL-6 levels were 5.2 pg/mL vs. 6.35 pg/mL respectively, p = ns. Cox regression model demonstrated that the treatment assigned is an independent predictor for no reflow occurrence (HR 0.34 95%, CI 0.18-0.61, p ≤0.001). CONCLUSION: The administration of a loading dose of 80 mg atorvastatin before primary PCI is an effective strategy for prevention of no reflow improving also clinical outcomes and free survival rate for the presentation of major adverse cardiovascular events at 30 d.


Assuntos
Angioplastia/métodos , Atorvastatina/uso terapêutico , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Fenômeno de não Refluxo/prevenção & controle , Intervenção Coronária Percutânea/métodos , Infarto do Miocárdio com Supradesnível do Segmento ST/terapia , Adulto , Idoso , Atorvastatina/administração & dosagem , Proteína C-Reativa/metabolismo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dados Preliminares , Taxa de Sobrevida , Resultado do Tratamento
2.
Arq Bras Cardiol ; 93(2): e33-5, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19838476

RESUMO

Non-compaction cardiomyopathy is a rare disease, anatomically characterized by a prominent trabecular pattern and deep intertrabecular recesses. Its clinical manifestations include severe left ventricular dysfunction, arrhythmias, systemic embolism, and sudden death. In this report, two cases of patients of different ages with non-compaction cardiomyopathy are described: a male schoolboy whose pathology was associated with mitral stenosis and regurgitation and a 50-year-old female with history of high blood pressure and cardiac failure.


Assuntos
Miocárdio Ventricular não Compactado Isolado/diagnóstico por imagem , Criança , Erros de Diagnóstico , Ecocardiografia Doppler em Cores , Saúde da Família , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
3.
Arq. bras. cardiol ; 93(2): e33-e35, ago. 2009. ilus
Artigo em Inglês, Espanhol, Português | LILACS | ID: lil-528317

RESUMO

A cardiomiopatia não-compactada é uma doença rara, anatomicamente caracterizada por um padrão trabecular proeminente e recessos intra-trabeculares profundos. Suas manifestações clínicas incluem disfunção ventricular grave arritmias, embolismo sistêmico e morte súbita. Nesse estudo, dois casos de pacientes de idades diferentes com cardiomiopatia não-compactada são descritos: uma criança do sexo masculino em idade escolar, cuja patologia estava associada com estenose mitral e regurgitação e um paciente adulto do sexo feminino, com 50 anos de idade e histórico de hipertensão arterial e insuficiência cardíaca.


Non-compaction cardiomyopathy is a rare disease, anatomically characterized by a prominent trabecular pattern and deep intertrabecular recesses. Its clinical manifestations include severe left ventricular dysfunction, arrhythmias, systemic embolism, and sudden death. In this report, two cases of patients of different ages with non-compaction cardiomyopathy are described: a male schoolboy whose pathology was associated with mitral stenosis and regurgitation and a 50-year-old female with history of high blood pressure and cardiac failure.


La miocardiopatía no compactada es una enfermedad rara, anatómicamente caracterizada por un patrón trabecular prominente y recesos intertrabeculares profundos. Sus manifestaciones clínicas incluyen disfunção ventricular gravem arritmias, embolismo sistémico y muerte súbita. En este estudio se describen dos casos de pacientes de edades diferentes con miocardiopatía no compactada: un niño de sexo masculino en edad escolar, cuya patología estaba asociada a estenosis mitral y regurgitación, y un paciente adulto del sexo femenino, con 50 años de edad e historia de hipertensión arterial e insuficiencia cardíaca.


Assuntos
Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Miocárdio Ventricular não Compactado Isolado , Erros de Diagnóstico , Ecocardiografia Doppler em Cores , Saúde da Família
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...